Owners, management and financials
CVR: 25589327
Secondary names: M Heltzen Holding ApS
Previous names: M HELTZEN HOLDING ApS
DKK -5,375
Gross profit
Net result: DKK -30,052
Michael Walter Heltzen (33,33-49,99%), MADS GINNERUP HOLDING ApS (33,33-49,99%)
1 more
CVR · view owners
Michael Walter Heltzen
CVR · view management
Active
Founded 4 December 2013
CVR · view overview
0 employees
Annual report 2025 · average
Name registered: Genomics Investment Syndicate III ApS
CVR · 15/06/2017
View the full event history
Genomics Investment Syndicate III ApS is a Danish company of the type Anpartsselskab based in Skive, founded in 2013. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named M HELTZEN HOLDING ApS. The management consists of Michael Walter Heltzen. The company is owned by Michael Walter Heltzen, MADS GINNERUP HOLDING ApS and Shawn Christopher Baker. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -5,375 and a net result of DKK -30,052 compared with DKK -644,469 the year before. Equity in the 2025 report amounted to DKK -403,227.
Selskabets formål er besiddelse af og investering i kapitalandele i andre selskaber samt andet efter direktionens skøn hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -5K | -30K | 482K | -403K | 0 | |
| 202401/01/2024 – 31/12/2024 | -6K | -644K | 482K | -373K | - | |
| 202301/01/2023 – 31/12/2023 | -9K | -32K | 1.1M | 271K | - | |
| 202201/01/2022 – 31/12/2022 | -7K | -31K | 1.1M | 304K | - | |
| 202101/01/2021 – 31/12/2021 | -6K | -28K | 1.1M | 335K | - | |
| 202001/01/2020 – 31/12/2020 | -6K | -100K | 1.1M | 363K | - | |
| 201901/01/2019 – 31/12/2019 | -6K | -242K | 1.2M | 462K | - | |
| 201801/01/2018 – 31/12/2018 | -5K | -25K | 1.4M | 704K | - | |
| 201701/01/2017 – 31/12/2017 | -12K | -23K | 1.4M | 729K | - | |
| 201601/01/2016 – 31/12/2016 | -4K | -4K | 756K | 245K | - | |
| 201501/01/2015 – 31/12/2015 | -3K | -1K | 256K | 249K | - | |
| 201401/01/2014 – 31/12/2014 | -5K | -5K | 254K | 250K | - | |
| 201301/01/2013 – 31/12/2013 | -4K | 110K | 260K | 256K | - |
Compared to 20.413 companies in Anden finansiel formidling i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of Genomics Investment Syndicate III ApS is 25589327.
Genomics Investment Syndicate III ApS is owned by Michael Walter Heltzen, MADS GINNERUP HOLDING ApS and Shawn Christopher Baker.
The management of Genomics Investment Syndicate III ApS consists of Michael Walter Heltzen.
In 2025, Genomics Investment Syndicate III ApS reported a gross profit of DKK -5,375.
Genomics Investment Syndicate III ApS had an average of 0 employees in the 2025 financial year according to the annual report.
Genomics Investment Syndicate III ApS was founded on 4 December 2013.
Claim this page to add your logo and social links. Free to get started.
Genomics Investment Syndicate III ApS has published its annual report for 2025. Gross profit came to DKK -5,375, and the net result was DKK -30,052.
Genomics Investment Syndicate III ApS has published its annual report for 2024. Gross profit came to DKK -5,942, and the net result was DKK -644,469.
Genomics Investment Syndicate III ApS has published its annual report for 2023. Gross profit came to DKK -8,700, and the net result was DKK -32,282.
Genomics Investment Syndicate III ApS has published its annual report for 2022. Gross profit came to DKK -7,375, and the net result was DKK -31,120.
Genomics Investment Syndicate III ApS has published its annual report for 2021. Gross profit came to DKK -5,657, and the net result was DKK -28,064.
Genomics Investment Syndicate III ApS has published its annual report for 2020. Gross profit came to DKK -6,125, and the net result was DKK -99,546.
Genomics Investment Syndicate III ApS has published its annual report for 2019. Gross profit came to DKK -5,927, and the net result was DKK -241,716.
Genomics Investment Syndicate III ApS has published its annual report for 2018. Gross profit came to DKK -4,500, and the net result was DKK -25,163.
Genomics Investment Syndicate III ApS has published its annual report for 2017. Gross profit came to DKK -12,105, and the net result was DKK -23,183.
Genomics Investment Syndicate III ApS has published its annual report for 2016. Gross profit came to DKK -4,366, and the net result was DKK -3,985.
On June 15, 2017, the company changed its name from M HELTZEN HOLDING ApS to Genomics Investment Syndicate III ApS.
As of June 15, 2017, Michael Walter Heltzen is registered as an owner of Genomics Investment Syndicate III ApS with an ownership share of 33%.
As of June 15, 2017, MADS GINNERUP HOLDING ApS is registered as an owner of Genomics Investment Syndicate III ApS with an ownership share of 33%.
As of June 15, 2017, is registered as an owner of Genomics Investment Syndicate III ApS with an ownership share of 33%.
Genomics Investment Syndicate III ApS has published its annual report for 2015. Gross profit came to DKK -2,938, and the net result was DKK -1,173.
Genomics Investment Syndicate III ApS has published its annual report for 2014. Gross profit came to DKK -5,364, and the net result was DKK -5,364.
Genomics Investment Syndicate III ApS has published its annual report for 2013. Gross profit came to DKK -3,901, and the net result was DKK 110,269.
As of December 4, 2013, Michael Walter Heltzen is registered as adm. dir. of Genomics Investment Syndicate III ApS.
Genomics Investment Syndicate III ApS was founded on December 4, 2013.
Companies in the same industry and area
CVR 10306442
CVR 11825109
CVR 10066050
CVR 38576046
CVR 10029457
